Company Filing History:
Years Active: 2007
Title: Yehudit Falcovitz-Gerassi: Innovator in Microarray Technology
Introduction
Yehudit Falcovitz-Gerassi is a prominent inventor based in San Diego, California. She has made significant contributions to the field of microarray technology, holding two patents that enhance the efficiency and accuracy of binding assays. Her work is instrumental in advancing biomedical research and diagnostics.
Latest Patents
Yehudit's latest patents include innovative solutions for alleviating non-specific binding in microarray assays. This patent describes a post-incubation treatment that effectively removes targets, such as proteins or other label-bearing moieties, that may non-specifically bind to a microarray substrate during a binding assay. The method involves a one-step wash with a liquid containing a digestive enzyme, which removes non-specifically bound targets, thereby reducing background noise during imaging.
Another notable patent is for a microwell biochip, which is formed from a thin flat plate of polymeric material with a plurality of regularly spaced holes that create microwells. This design allows for the retention of aqueous test solutions until a vacuum is applied, facilitating efficient drainage. The biochip incorporates biological capture agents that become immobilized within the polymerizing hydrogel, enhancing its functionality in various applications.
Career Highlights
Yehudit Falcovitz-Gerassi currently works at Biocept, Inc., where she continues to innovate in the field of microarray technology. Her expertise and dedication have positioned her as a key figure in her organization, contributing to advancements in diagnostic tools and methodologies.
Collaborations
Throughout her career, Yehudit has collaborated with notable colleagues, including Pavel Tsinberg and Pat Roycroft. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Yehudit Falcovitz-Gerassi is a trailblazer in the realm of microarray technology, with her patents significantly impacting the field. Her work at Biocept, Inc. and collaborations with esteemed colleagues highlight her commitment to advancing scientific research and diagnostics.